Moreover, in certain pathological states, like stroke and diabetes, blocking the CXCL12/CXCR4 axis by AMD3100 treatment led to elevated populations of activated macrophages in the ischemic cortex or skin wounds (46, 47). The gene discussed is CXCL12; the disease is stroke disorder.